Dysplastic lesion of unknown severity of the cervix uteri

N14_CERVICAL_DYSPLASIA_NOS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule only females	293218
2. Check conditions None	293218
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N87.9 Cause of death: ICD-10 — N87.9 2 out of 7 registries used, show all original rules.	391
4. Check minimum number of events None	391
5. Include endpoints None	391
6. Filter based on genotype QC (FinnGen only)	376

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	N14_CERVICAL_DYSPLASIA_NOS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N879
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N879
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dysplastic lesion of unknown severity of the cervix uteri based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2302	2302	-
Only index persons	2267	2267	-
Unadjusted period prevalence (%)
Whole population	0.07	0.07	-
Only index persons	0.08	0.08	-
Median age at first event (years)
Whole population	-	39.51	-
Only index persons	-	39.34	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	376	376	-
Unadjusted period prevalence (%)	0.13	0.13	-
Median age at first event (years)	40.03	40.03	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
391: Matched controls
3910

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N87.9

ICD-10 Finland

Dysplasia of cervix uteri, unspecified

+∞

307.7

391

ULA02

NOMESCO Finland

Kolposcopy

19.8

203.9

274

414

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

16.3

178.1

218

281

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

19.0

172.6

167

148

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

12.5

146.4

232

408

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

9.6

115.6

223

473

LDA10

NOMESCO Finland

Curettage of cervix uteri

12.9

112.9

130

145

N87.2

ICD-10 Finland

Severe cervical dysplasia, not elsewhere classified

14.2

91.8

8077/2-C53.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of cervix uteri

15.9

74.3

N87.0

ICD-10 Finland

Mild cervical dysplasia

11.6

71.2

N87.1

ICD-10 Finland

Moderate cervical dysplasia

10.6

50.9

A63.0

ICD-10 Finland

Anogenital (venereal) warts

6.0

27.5

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.4

15.3

217

1354

LEB00

NOMESCO Finland

Biopsy of vagina

6.2

13.7

SPAT1193

SPAT

Pap smear

2.4

10.4

429

8140/2-C53.9

ICD-O-3

Adenocarcinoma in situ, NOS, of cervix uteri

37.6

9.1

R87.5

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal microbiological findings

4.2

8.9

D06.0

ICD-10 Finland

Carcinoma in situ: Endocervix

13.4

7.9

R87.9

ICD-10 Finland

Abnormal findings in specimens from female genital organs, unspecified abnormal finding

18.8

7.6

LCD31

NOMESCO Finland

Radical laparoscopic hysterectomy

81.6

7.4

LCA06

NOMESCO Finland

Biopsy of endometrium

2.1

7.4

442

A63.8

ICD-10 Finland

Other specified predominantly sexually transmitted diseases

20.5

7.2

X86

ICPC

Abnormal cervix smear

6.5

7.0

WX704

NOMESCO Finland

Intubation

2.5

6.6

179

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.9

6.5

113

ZXC00

NOMESCO Finland

Use of diathermy

11.3

6.3

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

3.8

6.3

SPAT1324

SPAT

Screening procedure

1.8

6.3

131

866

LDB20

NOMESCO Finland

Electrocoagulation or laser therapy of cervix uteri

6.9

6.1

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

120

235

6.92

62.71

2.2

1.5

—

(3025130) Human papilloma virus identified in Specimen

110

9.31

61.46

2.3

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

212

1119

2.95

24.53

2.5

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

127

2.57

5.27

2.5

2.3

93.69

122.38

ng/l

0.21

117

(3019150) Specific gravity of Urine by Refractometry

100

695

1.59

3.70

3.5

3.1

1.02

kg/l

0.89

(3019897) Erythrocyte distribution width [Ratio] by Automated count

2.61

3.17

1.8

2.0

13.06

13.23

0.27

(3029937) Albumin [Presence] in Urine by Test strip

114

868

1.44

2.66

3.5

3.3

0.00

0.01

estimate

1.08

342

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

314

0.43

2.66

1.6

3.4

24.60

33.16

—

229

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

160

1295

1.40

2.64

3.3

3.1

—

(3035350) Ketones [Presence] in Urine by Test strip

197

1656

1.38

2.57

3.3

3.1

0.00

estimate

-0.00

353

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

3.39

2.40

2.0

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

197

1676

1.35

2.30

3.3

3.1

0.00

0.01

estimate

0.50

331

(3019225) pH of Specimen

241

0.40

2.27

2.6

3.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

130

1.90

2.17

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

116

915

1.38

2.17

2.8

2.2

54.66

56.73

u/l

0.29

109

850

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

4.33

2.16

1.2

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

287

3102

0.72

2.12

9.3

8.7

91.73

90.76

ml/min/173m2

0.34

215

2485

(40768804) Tissue Pathology biopsy report

176

1489

1.33

2.07

2.6

2.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

193

1656

1.33

2.05

4.4

4.3

0.00

estimate

0.50

345

(4200892) Spirometry reversibility

194

1.71

2.04

1.6

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

2.67

2.02

1.7

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

134

1.84

2.00

2.7

2.4

1.81

5.20

ug/l

1.83

119

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

690

1.40

1.98

1.2

1.3

18.62

29.46

iu/ml

1.00

254

(4035726) Immunohistochemistry procedure

236

1.63

1.96

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

3.79

1.94

2.0

2.5

43.73

50.46

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2.43

1.87

6.6

1.9

—

(3001019) Free T4 and TSH panel - Serum or Plasma

372

0.57

1.84

2.1

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

166

0.41

1.83

1.4

—

(3011288) Drugs identified in Urine by Screen method

137

0.36

1.78

1.2

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

165

1.68

1.70

1.7

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

2.22

1.69

1.0

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.93

1.68

4.4

8.9

—

(3013512) EKG study

683

0.69

1.64

2.0

2.9

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

130

1091

1.29

1.53

4.6

2.9

33.29

27.60

u/l

0.60

124

1047

(3000093) Morphology [Interpretation] in Blood Narrative

3.36

1.53

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

2.88

1.51

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

806

1.31

1.46

2.1

2.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.15

1.44

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

716

1.31

1.43

3.5

2.9

—

(3012544) pH of Venous blood

175

1.58

1.38

4.2

3.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

694

1.31

1.35

1.2

1.3

12.44

14.60

u/ml

0.08

286

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

2.12

1.31

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

2.52

1.31

3.8

2.1

515.67

505.89

e6/l

—

(3028300) Cannabinoids [Presence] in Urine

204

0.53

1.30

1.3

1.5

—

(40761535) Cells panel - Urine sediment

203

1.52

1.29

3.6

2.9

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

383

1.38

1.29

1.2

1.3

130.23

162.94

iu/ml

0.29

175

(3027008) Opiates [Presence] in Urine

203

0.53

1.28

1.3

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

544

1.33

1.28

1.4

707.50

494.21

titre

0.27

121

(3016879) Cocaine [Presence] in Urine

190

0.51

1.28

1.3

1.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

130

1113

1.25

1.27

4.5

3.9

36.28

36.83

g/l

0.55

123

1048

(3000764) Benzodiazepines [Presence] in Urine

202

0.53

1.26

1.3

1.5

—

(3027944) Amphetamines [Presence] in Urine

202

0.53

1.26

1.3

1.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

262

2426

1.24

1.22

3.8

10.00

9.59

mm/h

0.26

247

2266

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.86

1.21

1.4

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

745

0.75

1.19

1.6

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

2.33

1.19

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

251

1.43

1.15

1.6

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

243

1.44

1.14

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

313

1.38

1.12

1.8

2.0

1447.03

4271.24

u/l

1.15

137

(3044889) 12 lead EKG panel

224

2051

1.22

1.12

3.2

2.8

—

(3018418) pH of Serum or Plasma

805

1.26

1.12

5.8

3.2

7.40

—

152

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

253

2347

1.22

1.10

7.0

6.3

72.97

73.51

u/l

0.08

239

2207

(3037756) Immunofixation for Serum or Plasma

2.21

1.08

1.3

1.7

—

(3000991) Gas panel - Venous blood

145

1.55

1.08

5.9

7.1

—

(40768443) Skin Pathology biopsy report

121

0.49

1.07

1.0

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

335

1.35

1.04

2.1

2.2

5.80

5.71

umol/l

0.03

283

(3024928) Oxygen saturation in Venous blood

2.08

1.03

2.0

2.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.71

1.02

1.1

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.91

1.02

1.0

1.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

241

1.40

1.00

1.5

1.6

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

0.98

0.0

1.4

—

68.79

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.98

0.0

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

117

0.51

0.95

1.2

1.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

368

1.32

0.94

2.7

2.0

2.52

2.47

g/l

0.24

342

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

765

1.23

0.93

1.6

1.7

0.70

0.78

mg/l

0.27

575

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

147

1312

1.19

0.92

6.1

5.1

1.23

1.22

mmol/l

0.34

130

1117

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

167

1509

1.19

0.91

4.9

5.2

10.03

9.36

umol/l

0.46

156

1424

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

2.02

0.87

1.2

1.4

—

(21494755) Public health laboratory ask at order entry panel

518

0.77

0.85

1.2

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1.71

0.83

1.1

1.2

188.33

204.73

u/ml

—

(3019060) Gas panel - Arterial blood

105

1.55

0.83

4.9

4.6

—

(3026008) Bacteria identified in Urine by Culture

109

956

1.19

0.82

2.7

2.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.89

0.82

1.2

1.1

—

1.07

—

(1002224) Polysomnography panel

176

0.61

0.82

1.0

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1.74

0.80

1.3

1.8

6.29

5.42

mmol/24h

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

405

1.27

0.79

1.5

1.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

0.00

0.79

0.0

1.7

—

42.39

—

(4281824) Cell count and differential, peritoneal fluid

1.83

0.79

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

101

1147

0.84

0.79

1.8

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

226

1.35

0.79

1.6

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

0.51

0.79

1.4

1.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

360

1.28

0.79

1.6

1.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.64

0.79

1.5

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

123

1.49

0.79

1.4

1.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

415

1.26

0.78

3.5

2.1

0.83

0.92

e6/l

0.16

219

(3021901) Oxygen saturation in Capillary blood

1.78

0.76

3.5

1.9

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.78

0.76

1.2

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.68

0.75

1.1

1.4

—

(3019230) Fractional oxyhemoglobin in Venous blood

2.10

0.75

1.8

2.0

62.40

61.62

—

(3015736) pH of Urine

149

1353

1.16

0.74

3.4

2.8

5.75

5.86

—

133

(3044640) Blood type and Crossmatch panel - Blood

994

0.84

0.73

1.9

1.8

—

(3048689) Calprotectin [Mass/mass] in Stool

494

1.23

0.72

2.5

2.1

64.93

93.76

ug/g

0.70

384

(3021879) Hepatitis B virus core Ab [Presence] in Serum

320

1.28

0.71

1.8

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

1.93

0.71

1.2

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

1.93

0.71

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

271

2835

0.86

0.70

5.2

4.3

37.86

37.89

mmol/mol

0.02

255

2691

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.52

0.70

1.5

2.2

0.76

0.64

0.65

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

295

0.73

0.70

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.54

0.68

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.54

0.68

1.0

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.64

0.67

1.4

1.8

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1.64

0.67

1.1

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.59

0.66

1.1

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

425

1.23

0.65

2.9

3.1

172.29

361.48

ng/l

0.35

233

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

280

0.74

0.65

1.5

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1.60

0.65

3.1

1.9

9.29

7.98

kpa

—

(3022217) INR in Platelet poor plasma by Coagulation assay

115

1034

1.16

0.64

6.5

7.3

0.99

1.08

inr

3.08

344

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

279

0.74

0.64

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

279

0.74

0.64

1.5

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

557

1.20

0.64

1.7

1.6

440.32

40974067.30

pmol/l

1.05

493

(44813793) Dust mix specific IgE antibody measurement

1.73

0.64

1.6

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

312

0.75

0.63

1.1

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

278

0.74

0.63

1.5

1.4

—

(4034850) Laboratory test

101

0.59

0.63

14.8

5.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

359

3511

1.27

0.62

8.8

8.5

25.06

23.63

u/l

0.30

349

3422

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.48

0.62

1.5

2.2

1.39

1.11

0.41

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.68

0.61

1.4

2.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1.68

0.61

1.0

1.1

14.77

16.25

u/l

—

(3041354) Potassium [Moles/volume] in Venous blood

1.68

0.61

1.4

2.5

4.12

4.01

mmol/l

—

(3035285) Chloride [Moles/volume] in Venous blood

1.68

0.61

1.4

2.5

104.00

106.00

mmol/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

1.61

0.61

3.1

4.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

166

1.34

0.60

1.3

2.50

1.30

u/ml

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.00

0.59

0.0

1.1

—

120.44

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

111

0.62

0.59

1.0

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

113

0.61

0.59

1.4

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.58

0.0

2.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.68

0.57

1.2

1.3

—

(4062490) Immunoglobulin typing, IgG

1.63

0.56

1.3

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

805

0.86

0.55

1.5

1.4

2.66

2.17

g/l

1.31

520

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.59

0.54

2.8

2.1

—

(3021589) Normoblasts [#/volume] in Blood

135

1462

0.88

0.54

7.7

7.5

0.00

e9/l

0.99

117

1207

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1.55

0.53

1.7

4.5

—

4.03

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1082

0.87

0.53

1.7

95.01

99.23

pmol/l

0.42

579

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.44

0.52

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

107

972

1.14

0.52

1.9

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1.51

0.52

1.8

4.5

40.28

19.97

mg/l

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1.51

0.52

1.7

4.5

62.18

30.46

mg/l

—

(3042936) Bacteria identified in Isolate by Culture

372

1.21

0.51

2.3

1.9

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

326

1.22

0.51

3.2

2.2

26.52

22.89

0.85

275

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.39

0.51

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

198

1.28

0.51

1.8

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

523

1.17

0.50

1.6

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

110

1004

1.13

0.50

2.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

346

1.21

0.49

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

110

0.63

0.49

1.4

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

110

0.63

0.49

1.4

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.46

0.48

1.7

2.1

—

(3022313) Gas panel - Capillary blood

0.60

0.46

3.0

3.2

—

(3022145) Colonoscopy Study observation

349

1.20

0.45

1.4

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

678

0.86

0.45

2.7

2.1

301.46

5273.50

umol/l

2.75

625

(3000330) Specific gravity of Urine by Test strip

130

1.32

0.44

3.0

2.8

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

466

0.84

0.44

2.2

2.3

2.39

2.43

mmol/l

1.18

412

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.44

0.43

1.1

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.39

0.41

1.3

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

105

1.35

0.41

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.1

—

30.20

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.41

0.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.41

0.0

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.41

0.0

1.1

—

(3016750) Collection duration of Urine

0.00

0.40

0.0

2.4

—

517.91

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.40

0.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.40

0.0

2.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.40

0.0

1.8

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.00

0.40

0.0

1.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

294

2858

1.12

0.39

4.3

4.5

14.27

14.31

pmol/l

0.11

278

2694

(3050129) First trimester maternal screen panel - Serum or Plasma

317

1.18

0.39

1.4

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

374

3777

0.77

0.39

16.5

15.4

39.71

39.78

0.11

348

3610

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.1

—

26.10

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.00

0.39

0.0

2.9

—

36958.16

—

(3020961) Endomysium IgA Ab [Titer] in Serum

206

1.23

0.39

1.1

—

195.00

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

170

1.25

0.38

1.7

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1.40

0.37

1.1

—

12.50

—

(3019309) Folate [Moles/volume] in Red Blood Cells

405

1.15

0.36

1.8

1.6

1269.67

1204.90

nmol/l

0.23

314

(3008898) HLA-B27 [Presence]

208

1.22

0.36

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.47

0.36

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.47

0.36

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

723

1.12

0.35

2.1

1.9

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

1.40

0.35

1.8

2.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.34

0.34

1.2

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

238

1.19

0.33

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

164

1.23

0.33

1.5

2.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

523

1.13

0.33

1.9

2.0

—

(1761868) Lipid panel - Serum or Plasma

130

1377

0.92

0.33

2.4

2.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

110

1.28

0.32

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

169

1613

1.08

0.32

2.2

2.3

—

(36660697) Celiac disease serology panel - Serum

325

0.85

0.31

1.0

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1.30

0.30

2.1

2.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1.32

0.30

7.6

2.8

24.09

24.24

mmol/l

0.09

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

428

0.88

0.29

1.3

1.5

—

(3037121) Protein [Mass/volume] in Urine

1.32

0.28

3.5

2.9

0.40

0.16

g/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

737

0.91

0.28

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

603

0.90

0.28

1.4

24.95

21.89

nmol/l

0.80

525

(3026361) Erythrocytes [#/volume] in Blood

375

3779

0.81

0.27

16.7

15.5

4.41

4.45

e12/l

1.10

369

3703

(3010813) Leukocytes [#/volume] in Blood

375

3779

0.81

0.27

16.6

15.5

6.76

6.65

e9/l

0.44

368

3696

(3043238) Trisomy 21 risk [Likelihood] in Fetus

235

0.84

0.26

1.6

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.70

0.26

1.0

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

323

3280

0.91

0.25

3.9

2.87

2.90

mmol/l

0.20

304

3116

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

142

1.21

0.25

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

320

3249

0.92

0.24

3.6

4.82

4.85

mmol/l

0.30

309

3102

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

100

945

1.08

0.24

2.7

2.8

107.99

17.73

ng/l

0.51

449

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

0.70

0.24

1.2

1.5

3.17

3.63

mmol/l

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

496

1.10

0.24

2.4

2.7

669.86

642.02

ng/l

0.03

406

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

390

1.12

0.24

3.3

2.2

4.08

4.41

e6/l

0.09

194

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

799

1.08

0.23

1.7

1.6

1.33

1.35

mmol/l

0.09

703

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.32

0.23

1.0

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

263

0.87

0.23

4.6

2.3

40.12

32.20

u/l

0.47

221

(3002582) Erythrocytes [#/volume] in Urine

820

0.92

0.22

4.7

2.6

21.51

69.33

e6/l

1.44

610

(40761536) Microorganisms panel - Urine sediment

305

1.13

0.22

3.1

3.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.74

0.22

2.4

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.27

0.22

1.8

1.2

—

(3018010) Neutrophils/100 leukocytes in Blood

156

1619

0.94

0.22

5.8

5.0

55.49

56.41

0.48

145

1519

(3018095) Leukocytes [#/volume] in Urine

100

1053

0.93

0.22

4.9

3.0

72.49

55.42

e6/l

0.21

672

(3021788) Differential panel - Synovial fluid

1.22

0.22

1.2

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

645

0.92

0.22

4.8

3.7

9.45

7.53

mg/mmol

0.17

392

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1.19

0.21

1.6

2.52

95.48

u/ml

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.19

0.21

1.0

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

230

0.86

0.21

2.8

2.0

85.20

80.02

ml/min/173m2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

0.21

0.0

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.00

0.21

0.0

2.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

1.44

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.21

0.0

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

211

1.15

0.21

3.3

4.2

21.18

7.64

ug/l

0.49

167

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.21

0.0

3.8

—

329.00

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

229

0.87

0.20

1.5

1.4

—

(4146454) Self-monitoring of blood glucose

0.00

0.20

0.0

2.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

754

0.93

0.20

2.1

2.0

2.72

2.74

mg/l

0.02

650

(3022621) pH of Urine by Test strip

203

1.14

0.19

1.7

2.3

—

(3002385) Erythrocyte distribution width [Ratio]

310

3055

1.07

0.19

14.5

12.3

13.85

14.23

1.02

304

3021

(3049717) Cytology report of Urine Cyto stain

1.16

0.19

1.5

1.9

—

(3002256) Pathology report gross observation

425

1.09

0.19

1.3

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.13

0.18

1.5

1.4

—

(3005033) Fetal Nuchal fold Thickness US

227

0.87

0.18

1.5

1.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

974

0.94

0.18

4.5

2.6

—

(3000850) Epithelial cells [#/volume] in Urine

573

1.08

0.18

4.1

2.3

10.77

9.40

e6/l

0.12

505

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

282

2775

1.06

0.17

3.7

3.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

242

2372

1.05

0.17

2.8

40.72

33.90

u/l

0.67

231

2275

(3014007) Fractional oxyhemoglobin in Arterial blood

110

1.19

0.17

5.8

7.9

90.35

94.41

0.74

110

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

908

1.06

0.17

2.0

1.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

181

1858

0.95

0.17

3.0

2.8

70.58

62.86

ug/l

0.42

176

1765

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.72

0.17

1.2

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

236

2313

1.05

0.17

4.1

3.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.16

0.16

1.5

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

245

0.89

0.16

2.4

4.1

0.42

1.06

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

245

0.89

0.16

2.0

1.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

159

1635

0.95

0.16

5.9

5.2

30.66

29.65

0.66

149

1537

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.10

0.16

1.3

—

(3013115) Eosinophils [#/volume] in Blood

179

1745

1.05

0.15

5.8

5.6

0.17

e9/l

0.02

168

1558

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

320

3235

0.94

0.15

3.6

1.53

1.57

mmol/l

0.83

303

3079

(3006315) Basophils [#/volume] in Blood

163

1674

0.95

0.15

5.6

5.2

0.04

e9/l

0.53

147

1477

(3013650) Neutrophils [#/volume] in Blood by Automated count

186

1904

0.96

0.15

7.7

8.2

4.01

3.90

e9/l

0.28

170

1679

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

323

3263

0.94

0.14

4.9

5.1

1.69

2.08

mu/l

0.56

305

3100

(3017143) Hepatitis C virus Ab [Presence] in Serum

510

1.07

0.14

2.1

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

1.20

0.14

1.7

1.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

247

1.10

0.14

1.2

—

(3001604) Monocytes [#/volume] in Blood

163

1670

0.96

0.13

5.6

5.2

0.53

0.52

e9/l

0.17

148

1476

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

107

0.84

0.13

1.0

1.5

17.28

24.20

u/l

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

110

0.81

0.13

1.9

1.6

94.44

96.28

—

105

(3030467) Casts [#/volume] in Urine by Automated count

751

0.95

0.12

4.4

2.5

0.41

0.37

e6/l

0.05

551

(3022096) Basophils/100 leukocytes in Blood

154

1503

1.04

0.12

6.2

5.2

0.68

0.67

0.01

142

1393

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

271

0.92

0.11

1.9

2.8

—

(3045414) Leukocytes [Presence] in Urine

153

1.12

0.11

1.4

1.6

—

(40758558) Short blood count panel - Blood

814

1.04

0.09

6.0

6.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1.04

0.09

1.4

3.1

13.78

75.93

u/ml

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

137

1399

0.97

0.09

2.3

2.2

75.01

75.29

nmol/l

0.04

127

1296

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

126

1.12

0.09

2.6

2.1

—

(3019198) Lymphocytes [#/volume] in Blood

170

1729

0.97

0.09

5.9

5.2

1.94

2.01

e9/l

0.38

162

1564

(3002179) Metamyelocytes/100 leukocytes in Blood

226

0.93

0.08

2.4

3.9

0.67

0.92

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.78

0.08

1.4

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.77

0.08

1.4

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

338

3360

1.04

0.08

11.6

10.2

22.56

18.43

mg/l

1.25

259

2543

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.03

0.08

1.3

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

0.80

0.07

1.0

1.5

—

(3012516) Albumin [Mass/volume] in Urine

620

0.96

0.07

4.2

3.1

57.87

274.71

mg/l

0.71

387

(3000492) Spirometry study

314

1.06

0.07

1.7

1.3

—

(3025941) Bacteria identified in Stool by Culture

216

1.07

0.07

1.4

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

128

1.10

0.07

1.4

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

152

0.92

0.06

1.8

1.7

—

(3025159) Blasts/100 leukocytes in Blood

223

0.94

0.06

2.4

4.2

0.00

0.08

—

(3006504) Eosinophils/100 leukocytes in Blood

155

1571

0.98

0.06

5.8

5.1

2.93

2.69

0.66

144

1468

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

117

1154

1.02

0.04

7.0

4.5

1.23

1.22

mmol/l

0.24

109

1071

(36304419) Bacteria [Presence] in Urine

764

0.98

0.04

4.3

2.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

325

3263

0.98

0.04

11.9

10.0

3.91

3.90

mmol/l

0.24

317

3160

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

129

0.93

0.03

2.2

—

(3000494) Fungus identified in Specimen by Culture

351

0.97

0.03

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

168

1665

1.02

0.03

4.3

3.8

6.31

6.27

mmol/l

0.09

151

1495

(3021440) Promyelocytes/100 leukocytes in Blood

230

0.95

0.03

2.4

4.2

0.00

0.12

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

240

0.96

0.03

1.1

1.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

250

1.04

0.03

1.2

—

24.09

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

481

0.97

0.03

1.6

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

310

1.04

0.03

6.9

4.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

181

1.05

0.03

1.4

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

551

0.98

0.03

1.5

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

324

3251

0.98

0.03

11.8

10.0

139.39

139.62

mmol/l

0.81

316

3160

(40760892) CBC W Ordered Manual Differential panel - Blood

157

1581

0.99

0.02

5.4

5.5

—

(40761511) CBC panel - Blood by Automated count

356

3568

0.97

0.02

10.6

9.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

933

1.01

0.01

1.2

1.3

0.61

2.07

u/ml

1.61

269

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

126

0.95

0.00

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

146

0.96

0.00

1.4

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

107

1068

1.00

0.00

2.2

1.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

211

0.99

0.00

1.8

1.3

269.49

261.19

miu/ml

—

110

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

113

0.97

0.00

1.7

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

157

1.02

0.00

15.7

6.1

9.73

7.13

mmol/l

0.70

149

(40768797) Stomach Pathology biopsy report

403

0.99

0.00

1.1

1.2

—

(3026782) Osmolality of Urine

535

1.01

0.00

3.4

2.5

506.36

523.16

mosm/kgh2o

0.26

454

(3036481) Cortisol [Moles/volume] in Serum or Plasma

316

1.01

0.00

1.8

2.0

377.04

375.48

nmol/l

0.01

298

(3023368) Bacteria identified in Blood by Culture

576

1.01

0.00

3.9

3.3

—

(3019069) Monocytes/100 leukocytes in Blood

157

1575

0.99

0.00

6.3

5.4

8.11

7.91

0.40

146

1475

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1.00

0.00

1.9

3.9

59.14

59.26

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.00

-0.00

0.0

1.6

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

0.00

-0.00

0.0

1.1

—

441.43

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.89

-0.00

1.2

1.1

—

(3020891) Body temperature

0.97

-0.00

6.7

4.1

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

-0.00

0.0

2.8

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

6.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

-0.00

0.0

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

-0.00

0.0

16.0

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

1.01

-0.00

1.9

3.3

4.00

4.56

e9/l

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.00

-0.00

0.0

1.3

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

310

3100

1.00

-0.00

3.1

3.2

1.21

1.19

mmol/l

0.22

293

2936

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

-0.00

0.0

1.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.00

-0.00

0.0

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3018133) Calcium [Moles/volume] in Urine

0.00

-0.00

0.0

1.7

—

3.71

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

-0.00

0.0

2.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1.00

-0.00

1.1

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3051339) Copper [Moles/volume] in Blood

0.00

-0.00

0.0

1.2

—

15.93

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

-0.00

0.0

1.4

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

3.6

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.04

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

0.92

-0.00

2.1

1.9

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

-0.00

0.0

1.7

—

132.78

—

(3014271) Vancomycin [Susceptibility]

0.00

-0.00

0.0

1.9

—

(3017509) Phencyclidine [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(3019174) dRVVT (LA screen)

0.00

-0.00

0.0

1.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(37021550) Renin [Units/volume] in Plasma --upright

0.00

-0.00

0.0

1.1

—

145.39

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

0.88

-0.00

14.5

2.9

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.4

—

(3047189) Immunofixation for 24 hour Urine

0.00

-0.00

0.0

2.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3035880) pH of Pleural fluid

0.00

-0.00

0.0

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

0.00

-0.00

0.0

1.3

—

41.12

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

312

3120

1.00

-0.00

3.5

5.61

5.63

mmol/l

0.14

290

2926

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.00

-0.00

0.0

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

-0.00

0.0

1.9

—

(3032057) Clostridioides difficile [Presence] in Stool

0.00

-0.00

0.0

2.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.7

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

-0.00

0.0

8.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_CERVICAL_DYSPLASIA_NOS and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_CERVICAL_DYSPLASIA_NOS	1.369 [1.07, 1.75]	0.012
Birth year	0.993 [0.98, 1.0]	0.115

During the follow-up period (1.1.1998 — 31.12.2019), 106 out of 1959 females with N14_CERVICAL_DYSPLASIA_NOS died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_CERVICAL_DYSPLASIA_NOS.

N-year risk	Females	Males
1	0.13%	No data
5	0.761%	No data
10	1.873%	No data
15	3.773%	No data
20	6.533%	No data

Relationships between endpoints

↥

Index endpoint: N14_CERVICAL_DYSPLASIA_NOS – Dysplastic lesion of unknown severity of the cervix uteri

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Dysplastic lesion of unknown severity of the cervix uteri

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints